Association of oxidative stress with motor neuron disease in horses

Hussni O. Mohammed Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Hussni O. Mohammed in
Current site
Google Scholar
PubMed
Close
 BVSc, MPVM, PhD
,
Thomas J. Divers Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Thomas J. Divers in
Current site
Google Scholar
PubMed
Close
 DVM
,
Justin Kwak Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Justin Kwak in
Current site
Google Scholar
PubMed
Close
 MS, MD
,
Adil H. Omar Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Adil H. Omar in
Current site
Google Scholar
PubMed
Close
,
Maurice E. White Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Maurice E. White in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Alexander de Lahunta Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Alexander de Lahunta in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

Objective—To investigate the influence of oxidative stress in terms of antioxidant capacity and lipid peroxidation on the probability of motor neuron disease (MND) in horses.

Animals—88 horses with MND (cases) and 49 controls.

Procedures—Blood samples were collected from all horses enrolled, and RBCs and plasma were harvested. Activity of the enzyme erythrocytic superoxide dismutase 1 (SOD1) was determined in the RBCs. Plasma concentrations of α-tocopherols and β-carotenes and activity of glutathione peroxidase were also evaluated. Degree of lipid peroxidation was measured by determining plasma concentrations of lipid hydroperoxides. Differences were evaluated between horse groups.

Results—Cases had lower erythrocyte SOD1 activity than did controls, but the difference was not significant. On the other hand, plasma vitamin E concentrations differed significantly between groups, with the cases having lower concentrations. Neither plasma vitamin A concentration nor glutathione peroxidase activity differed between groups; however, cases had significantly higher concentrations of lipid hydroperoxides (18.53μM) than did controls (12.35μM).

Conclusions and Clinical Relevance—Horses with MND differed from those without MND by having a lower plasma concentration of vitamin E and higher concentrations of lipid hydroperoxides. Results parallel the findings in humans with sporadic amyotrophic sclerosis and provide evidence supporting the involvement of oxidative stress in the 2 conditions.

Abstract

Objective—To investigate the influence of oxidative stress in terms of antioxidant capacity and lipid peroxidation on the probability of motor neuron disease (MND) in horses.

Animals—88 horses with MND (cases) and 49 controls.

Procedures—Blood samples were collected from all horses enrolled, and RBCs and plasma were harvested. Activity of the enzyme erythrocytic superoxide dismutase 1 (SOD1) was determined in the RBCs. Plasma concentrations of α-tocopherols and β-carotenes and activity of glutathione peroxidase were also evaluated. Degree of lipid peroxidation was measured by determining plasma concentrations of lipid hydroperoxides. Differences were evaluated between horse groups.

Results—Cases had lower erythrocyte SOD1 activity than did controls, but the difference was not significant. On the other hand, plasma vitamin E concentrations differed significantly between groups, with the cases having lower concentrations. Neither plasma vitamin A concentration nor glutathione peroxidase activity differed between groups; however, cases had significantly higher concentrations of lipid hydroperoxides (18.53μM) than did controls (12.35μM).

Conclusions and Clinical Relevance—Horses with MND differed from those without MND by having a lower plasma concentration of vitamin E and higher concentrations of lipid hydroperoxides. Results parallel the findings in humans with sporadic amyotrophic sclerosis and provide evidence supporting the involvement of oxidative stress in the 2 conditions.

Contributor Notes

Supported in part by grants from the NIH and The Lowe Foundation.

Address correspondence to Dr. Mohammed (hom1@cornell.edu).
  • 1. Cummings JF, George C, de Lahunta A, et alEquine motor neuron disease: a preliminary report. Cornell Vet 1990;80:357379.

  • 2. Rowland LP. Progressive muscular atrophy and other lower motor neuron syndromes of adults. Muscle Nerve 2010;41:161165.

  • 3. Divers TJ, Cummings JE, de Lahunta A, et alEvaluation of the risk of motor neuron disease in horses fed a diet low in vitamin E and high in copper and iron. Am J Vet Res 2006;67:120126.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4. Cummings JF, de Lahunta A, Summers BA, et alEosinophilic cytoplasmic inclusions in sporadic equine motor neuron disease: an electron microscopic study. Acta Neuropathol (Berl) 1993;85:291297.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5. Mohammed HO, Divers TJ, Summers BA, et alVitamin E deficiency and risk of equine motor neuron disease. Acta Vet Scand 2007;49:17.

  • 6. Rua-Domenech R, Mohammed HO, Cummings JF, et alIntrinsic, management, and nutritional factors associated with equine motor neuron disease. J Am Vet Med Assoc 1997;211:12611267.

    • Search Google Scholar
    • Export Citation
  • 7. Riis RC, Jackson C, Rebhun W, et alOcular manifestations of equine motor neuron disease. Equine Vet J 1999;31:99110.

  • 8. Adibhatla RM, Hatcher JF. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2010;12:125169.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9. Baillet A, Chanteperdrix V, Trocme C, et alThe role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease. Neurochem Res 2010;35:15301537.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10. Bowling AC, Schulz JB, Brown RH Jr, et alSuperoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993;61:23222325.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11. Rua-Domenech R, Wiedmann M, Mohammed HO, et alEquine motor neuron disease is not linked to Cu/Zn superoxide dismutase mutations: sequence analysis of the equine Cu/Zn superoxide dismutase cDNA. Gene 1996;178:8388.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12. Divers TJ, Mohammed HO, Cummings JF, et alEquine motor neuron disease: findings in 28 horses and proposal of a pathophysiological mechanism for the disease. Equine Vet J 1994;26:409415.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13. Paoletti F, Mocali A. Changes in CuZn-superoxide dismutase during induced differentiation of murine erythroleukemia cells. Cancer Res 1988;48:66746677.

    • Search Google Scholar
    • Export Citation
  • 14. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158169.

    • Search Google Scholar
    • Export Citation
  • 15. Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 2010;48:629641.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16. Ihara Y, Nobukuni K, Takata H, et alOxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation. Neurol Res 2005;27:105108.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17. Butterfield DA, Castegna A, Drake J, et alVitamin E and neurodegenerative disorders associated with oxidative stress. Nutr Neurosci 2002;5:229239.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18. Tuncel D, Aydin N, Aribal KP, et alRed cell superoxide dismutase activity in sporadic amyotrophic lateral sclerosis. J Clin Neurosci 2006;13:991994.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19. Bachus R, Claus A, Megow D, et alCu, Zn SOD in German families with ALS. J Neurol Sci 1995;129(suppl):9395.

  • 20. Brooks BR. Managing amyotrophic lateral sclerosis: slowing disease progression and improving patient quality of life. Ann Neurol 2009;65(suppl 1):S17S23.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21. Okamoto K, Kihira T, Kobashi G, et alFruit and vegetable intake and risk of amyotrophic lateral sclerosis in Japan. Neuroepidemiology 2009;32:251256.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22. Wang H, O'Reilly EJ, Weisskopf MG, et alVitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies. Am J Epidemiol 2011;173:595602.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23. Molina JA, de BF, Jimenez-Jimenez FJ, et alSerum levels of coenzyme Q10 in patients with amyotrophic lateral sclerosis. J Neural Transm 2000;107:10211026.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24. Kato S, Kato M, Abe Y, et alRedox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models. Acta Neuropathol 2005;110:101112.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25. Miana-Mena FJ, Gonzalez-Mingot C, Larrode P, et alMonitoring systemic oxidative stress in an animal model of amyotrophic lateral sclerosis. J Neurol 2011;258:762769.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26. Bonnefont-Rousselot D, Lacomblez L, Jaudon M, et alBlood oxidative stress in amyotrophic lateral sclerosis. J Neurol Sci 2000;178:5762.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27. Oteiza PI, Uchitel OD, Carrasquedo F, et alEvaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients. Neurochem Res 1997;22:535539.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28. Tateishi T, Yoshimine N, Kuzuya F. Serum lipid peroxide assayed by a new colorimetric method. Exp Gerontol 1987;22:103111.

  • 29. Rua-Domenech R, Mohammed HO, Cummings JF, et alAssociation between plasma vitamin E concentration and the risk of equine motor neuron disease. Vet J 1997;154:203213.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30. Mohammed HO, Starkey SR, Stipetic K, et alThe role of dietary insufficiency with antioxidants on the permeability of the blood-brain barrier. J Neuropathol Exp Neurol 2008;67:11871193.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31. Divers TJ, Mohammed HO, Hintz HF, et alEquine motor neuron disease: a review of clinical and experimental studies. Equine Pract 2006;5:2429.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32. Williams CA, Hoffman RM, Kronfeld DS, et alLipoic acid as an antioxidant in mature thoroughbred geldings: a preliminary study. J Nutr 2002;132:16281631.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement